Standard Biotools (LAB) Capital Expenditures Growth (5y) (2015 - 2026)
Standard Biotools (LAB) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.02 Bn | 179.73 Bn | 6.27 Bn |
| 2 | Stryker | 132.07 Bn | 129.19 Bn | 3.81 Bn |
| 3 | Medtronic | 111.38 Bn | 102.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.98 Bn | 67.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn |
| 6 | Dexcom | 28.91 Bn | 27.80 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.83 Bn | 26.55 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 28.10 Bn | 27.52 Bn | - |
| 9 | Koninklijke Philips | 24.30 Bn | 21.26 Bn | 2.01 Bn |
| 10 | Standard Biotools | 302.10 Mn | -153.08 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.96% |
| Dec 31, 2025 | -41.78% |
| Sep 30, 2025 | -16.45% |
| Jun 30, 2025 | -57.20% |
| Mar 31, 2025 | 37.45% |
| Dec 31, 2024 | -52.76% |
| Sep 30, 2024 | 29.87% |
| Jun 30, 2024 | -31.04% |
| Mar 31, 2024 | 24.04% |
| Dec 31, 2023 | -168.54% |
| Sep 30, 2023 | 35.52% |
| Jun 30, 2023 | 61.19% |
| Mar 31, 2023 | 67.33% |
| Dec 31, 2022 | 33.51% |
| Sep 30, 2022 | 17.94% |
| Jun 30, 2022 | 45.88% |
| Mar 31, 2022 | 4.64% |
| Dec 31, 2021 | -6.35% |
| Sep 30, 2021 | 49.59% |
| Jun 30, 2021 | 48.86% |